期刊文献+

基于分子对接技术模拟预测复明片对M胆碱受体的作用 被引量:1

下载PDF
导出
摘要 【目的】采用分子对接技术模拟预测复明片与M胆碱受体的作用关系。【方法】建立复明片活性成分数据库,采用Autodocking vina等软件,以M胆碱受体蛋白激动剂IX0作为配体,建立M胆碱受体蛋白的活性位点,对复明片中活性成分进行分子对接模拟预测。【结果】以自带配体IX0(-6.5 kcal/mol)为阈值,复明片中共有217种成分与M胆碱受体蛋白对接亲和力在阈值之上。复明片中活性成分主要作用于以ALA-194、ASN-108、ASN-404、ASP-103、CYS-429、PHE-195、SER-107、TRP-155、TRP-400、TYR-403、TYR-426、TYR-430、VAL-111等氨基酸残基组成的活性位点。【讨论】复明片中活性成分与M胆碱受体蛋白能够成功进行分子对接,其对接位点信息有助于研究复明片活性物质与M胆碱受体的作用机制的阐释及发现新型抗青光眼药物提供参考。 Objective:The molecular docking technology was used to simulate and predict the relationship between Fumingpian tablets and M choline receptors.Methods:We established the active ingredient database of Fumingpian tablets,used software such as Autodocking vina,and used M choline receptor protein agonist IX0 as a ligand,so as to establish the active site of M choline receptor protein and perform molecular analysis on the active ingredients in Fumingpian tablets Docking simulation prediction.Results:Taking the self-ligand IX0(-6.5 kcal/mol)as the threshold,a total of 217 components in Fumingpian tablets have a docking affinity with M choline receptor protein above the threshold.The active ingredients in Fumingpian tablets mainly act on ALA-194,ASN-108,ASN-404,ASP-103,CYS-429,PHE-195,SER-107,TRP-155,TRP-400,TYR-403,TYR-426,TYR-430,VAL-111 and other active sites composed of amino acid residues.Discussion:The active components of Fumingpian tablets can successfully dock with M-choline receptor proteins,and the information of their binding sites is helpful to study themechanism of interaction between active substances and M-choline receptors,and provide a reference for the discovery of new anti-glaucoma drugs.
出处 《科技创新与应用》 2020年第21期5-7,11,共4页 Technology Innovation and Application
关键词 复明片 活性成分 M胆碱受体蛋白 分子对接 Fumingpian tablets active ingredients M choline receptor protein molecular docking
  • 相关文献

参考文献6

二级参考文献54

  • 1郭权,王希诚,李纯莲.药物分子对接中应用网格的研究与进展[J].计算机研究与发展,2004,41(12):2054-2059. 被引量:7
  • 2李蓓,郑燕林,刘文舟.中药复明片治疗原发性开角型青光眼视功能损害的疗效研究[J].国际眼科杂志,2007,7(1):269-273. 被引量:20
  • 3Collins J G,Sleeman A D,Aldrich-Wright J R,Greguric I, Hambley T W. Inorg. Chem. [J],1998,37(13) :3133.
  • 4Eriksson M, Leijon M, Hiort C, Norden B, Graslund A. J. Am. Chem. Soc. [J], 1992,114 : 4933.
  • 5Perola E. Prot. Struct. Funct. Bioi. [J] ,2006,64(2) ..422.
  • 6Taylor P D,Jewsbury P J, Essex J W. J. Comput.-Aided Mol. Des. [J] ,2002,16:151.
  • 7Congreve M,Murray C W,Blundell T L. Drug Discovery Today[J].2005,10(13) :895.
  • 8Stockwell B R, Nature[J], 2004,432 : 846.
  • 9Fahmy A,Wagner G. J. Am. Chem. Soc. [J] ,2002,124(7) : 1241.
  • 10Audie J, Scarlata S. Biophysical Chemistry[J], 2007,129: 198.

共引文献97

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部